Vanguard Group’s Inhibrx INBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.54M | Buy |
598,448
+10,125
| +2% | +$144K | ﹤0.01% | 2988 |
|
|
2025
Q1 | $8.23M | Sell |
588,323
-19,398
| -3% | -$271K | ﹤0.01% | 2954 |
|
|
2024
Q4 | $9.36M | Buy |
607,721
+77,663
| +15% | +$1.2M | ﹤0.01% | 2996 |
|
|
2024
Q3 | $8.3M | Buy |
530,058
+52,030
| +11% | +$815K | ﹤0.01% | 3053 |
|
|
2024
Q2 | $6.77M | Buy |
+478,028
| New | +$6.77M | ﹤0.01% | 3115 |
|